NOVT trades 43.5% below Wall Street's consensus target of $194.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes NOVT achieves its forward estimates and maintains a stable P/E multiple of 36.6x. This scenario reflects the blended consensus of 3 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of November 7, 2026, Novanta Inc. (NOVT) has a Wall Street consensus price target of $194.00, based on estimates from 3 covering analysts. With the stock currently trading at $135.15, this represents a potential upside of +43.5%. The company has a market capitalization of $4.81B.
Analyst price targets range from a low of $194.00 to a high of $194.00, representing a 0% spread in expectations. The median target of $194.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 2 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, NOVT trades at a trailing P/E of 90.1x and forward P/E of 36.6x. The forward PEG ratio of 11.10 reflects a premium valuation. Analysts expect EPS to grow +146.2% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $103.52, with bear and bull scenarios of $65.22 and $136.40 respectively. Model confidence stands at 42/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 MKSIMKS Inc. | $13.0B | $192.27 | $401.86 | +109.0% | Buy | 14.6x | 29 |
 CGNXCognex Corporation | $8.0B | $47.78 | $75.36 | +57.7% | Hold | 28.4x | 32 |
 COHRCoherent, Inc. | $37.7B | $192.81 | $379.80 | +97.0% | Buy | 35.2x | 31 |
 KLICKulicke and Soffa Industries, Inc. | $3.3B | $64.01 | $62.50 | -2.4% | Buy | 16.6x | 11 |
 IPGPIPG Photonics Corporation | $2.8B | $65.31 | $121.00 | +85.3% | Buy | 59.2x | 27 |
 AEISAdvanced Energy Industries, Inc. | $7.5B | $197.01 | $416.00 | +111.2% | Buy | 15.9x | 27 |
 LSCCLattice Semiconductor Corporation | $14.4B | $105.02 | $178.13 | +69.6% | Buy | 41.8x | 17 |
 VIAVViavi Solutions Inc. | $7.0B | $28.47 | $63.67 | +123.6% | Buy | 30.4x | 19 |
 ISRGIntuitive Surgical, Inc. | $160.0B | $452.80 | $485.44 | +7.2% | Buy | 40.3x | 57 |
 SYKStryker Corporation | $124.9B | $325.87 | $354.47 | +8.8% | Buy | 22.0x | 52 |
Quick answers to the most common questions about buying NOVT stock.
The consensus Wall Street price target for NOVT is $194, representing 43.5% upside from the current price of $135.15. With 3 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
NOVT has a consensus rating of "Buy" based on 3 Wall Street analysts. The rating breakdown is predominantly bullish, with 2 Buy/Strong Buy ratings. The consensus 12-month price target of $194 implies 43.5% upside from current levels.
At a forward P/E of 36.5933x, NOVT trades at a premium valuation. The consensus price target of $194 (43.5% upside) suggests analysts still see growth justifying the multiple.
The most bullish Wall Street analyst has a price target of $194 for NOVT, while the most conservative target is $194. The consensus of $194 represents the median expectation. Our quantitative valuation model projects a bull case target of $136 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
NOVT is lightly followed, with 3 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month NOVT stock forecast based on 3 Wall Street analysts shows a consensus price target of $194, with estimates ranging from $194 (bear case) to $194 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $104, with bear/bull scenarios of $65/$136.
Our quantitative valuation model calculates NOVT's fair value at $104 (base case), with a bear case of $65 and bull case of $136. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 42/100.
NOVT trades at a forward P/E ratio of 36.6x based on next-twelve-months earnings estimates compared to a trailing P/E of 90.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on NOVT, with a "Buy" consensus rating and $194 price target (43.5% upside). 2 of 3 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
NOVT analyst price targets range from $194 to $194, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $194 consensus represents the middle ground. Our model's $65-$136 range provides an independent fundamental perspective.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.